Home  > 
  Sancilio Pharma's Altemia receives US FDA rare pediatric disease status for treatment of SCDi n children,   September 21, 2017
  WHO report shows world is running out of antibiotics,   September 21, 2017
  Novartis' Rydapt gets EU approval for newly diagnosed FLT3-mutated acute AML & 3 types of advanced SM,   September 20, 2017
  Pfizer announces outcome of FDA committee meeting for Sutent in patients at high risk of recurrent RCC after surgery,   September 20, 2017
  US FDA approves once-daily single inhaler triple therapy, Trelegy Ellipta to treat patients with COPD,   September 19, 2017
  Neos Therapeutics' Adzenys ER oral suspension receives US FDA approval to treat ADHD,   September 19, 2017
  US FDA grants priority review status to Braeburn's CAM2038 buprenorphine depot to treat opioid use disorder,   September 19, 2017
  EMA committee recommends approval of Janssen's Tremfya to treat patients with moderate to severe plaque psoriasis,   September 19, 2017
  US FDA approves Aliqopa to treat adults with relapsed follicular lymphoma,   September 16, 2017
  Kyowa Hakko Kirin joins Certara‚Äôs Simcyp Consortium,   September 16, 2017
  Aethlon Medical gets NCI contract award,   September 16, 2017
  UCB's antiepileptic drug Briviact receives US FDA approval to treat partial-onset seizures in adults,   September 16, 2017
  Janssen seeks US FDA approval to expand indication of Zytiga to treat patients with earlier stages of metastatic prostate cancer,   September 16, 2017
  US FDA approves Mvasi for treatment of five types of cancer,   September 16, 2017
  Caprion Biosciences' Montreal laboratory receives CAP accreditation & CLIA certification,   September 15, 2017
  Aspen acquires remaining rights to anaesthetics medicines from AstraZeneca,   September 15, 2017
  US FDA committee recommends GSK's Shingrix for prevention of herpes zoster in adults ages 50 and over,   September 15, 2017
  Vaximm's oral T-cell immunotherapy VXM01 to treat glioma receives European & US orphan drug designation,   September 14, 2017
  Aethlon gets US FDA EAP designation to accelerate US access to Hemopurifier to treat life-threatening viruses,   September 14, 2017
  Allergan launches new Brilliant Distinctions patient loyalty programme,   September 14, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |